Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
In the latest session, SeaStar Medical Holding Corp (NASDAQ: ICU) closed at $0.31 down -3.49% from its previous closing price of $0.32. In other words, the price has decreased by -$3.49 from its previous closing price. On the day, 0.75 million shares were traded. ICU stock price reached its highest trading level at $0.3358 during the session, while it also had its lowest trading level at $0.3052.
Ratios:
For a deeper understanding of SeaStar Medical Holding Corp’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.64 and its Current Ratio is at 3.66. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 09 ’25 when Messinger Michael bought 14,500 shares for $0.35 per share. The transaction valued at 5,098 led to the insider holds 17,500 shares of the business.
Van Heel Kenneth bought 25,000 shares of ICU for $22,248 on Aug 26 ’25. The Director now owns 39,400 shares after completing the transaction at $0.89 per share. On Aug 27 ’25, another insider, Van Heel Kenneth, who serves as the Director of the company, bought 10,000 shares for $0.86 each. As a result, the insider paid 8,565 and bolstered with 49,400 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ICU now has a Market Capitalization of 10569890 and an Enterprise Value of -2588388. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.70 while its Price-to-Book (P/B) ratio in mrq is 0.92. Its current Enterprise Value per Revenue stands at -2.938.
Stock Price History:
The Beta on a monthly basis for ICU is -1.01, which has changed by -0.8386935 over the last 52 weeks, in comparison to a change of 0.12838376 over the same period for the S&P500. Over the past 52 weeks, ICU has reached a high of $3.07, while it has fallen to a 52-week low of $0.29. The 50-Day Moving Average of the stock is -34.00%, while the 200-Day Moving Average is calculated to be -66.96%.
Shares Statistics:
For the past three months, ICU has traded an average of 2.66M shares per day and 1709440 over the past ten days. A total of 36.05M shares are outstanding, with a floating share count of 35.79M. Insiders hold about 0.68% of the company’s shares, while institutions hold 3.03% stake in the company. Shares short for ICU as of 1764288000 were 3074030 with a Short Ratio of 1.16, compared to 1761868800 on 616671. Therefore, it implies a Short% of Shares Outstanding of 3074030 and a Short% of Float of 8.59.
Earnings Estimates
Current recommendations for the stock of the company come from 1.0 analysts. The consensus estimate for the next quarter is -$0.11, with high estimates of -$0.11 and low estimates of -$0.11.
Analysts are recommending an EPS of between -$0.63 and -$0.63 for the fiscal current year, implying an average EPS of -$0.63. EPS for the following year is -$0.44, with 1.0 analysts recommending between -$0.44 and -$0.44.
Revenue Estimates
A total of 1 analysts believe the company’s revenue will be $245k this quarter.It ranges from a high estimate of $245k to a low estimate of $245k. As of. The current estimate, SeaStar Medical Holding Corp’s year-ago sales were $67kFor the next quarter, 1 analysts are estimating revenue of $375k. There is a high estimate of $375k for the next quarter, whereas the lowest estimate is $375k.
A total of 1 analysts have provided revenue estimates for ICU’s current fiscal year. The highest revenue estimate was $1.06M, while the lowest revenue estimate was $1.06M, resulting in an average revenue estimate of $1.06M. In the same quarter a year ago, actual revenue was $135kBased on 1 analysts’ estimates, the company’s revenue will be $1.74M in the next fiscal year. The high estimate is $1.74M and the low estimate is $1.74M.
